Gene Amplification Technologies Market by Technology, Application, End User, Key Players and Regions - Global Industry Analysis & Forecast to 2027
Published On : August 2022 Pages : 185 Category: Pharma & Healthcare Report Code : HC0817406
The global Gene Amplification Technologies Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.
The report exhibit detail coverage of Gene Amplification Technologies industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of Gene Amplification Technologies Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Gene Amplification Technologies Market for 2017-2022.
Crystal Market Research envisions that the span of the Gene Amplification Technologies Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.
Our research study analyses the size of the global market of Gene Amplification Technologies in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Gene Amplification Technologies Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.
To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Gene Amplification Technologies Market on the basis of fabric, product, application, and region:
By Region
- North America (US, Canada)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Mexico, Columbia, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Danaher Corporation
- 4basebio AG
- LGC Group
- Vazyme Biotech Co. Ltd.
- MyBioSource
- Takara Bio Inc.
- Promega Corporation
- Merck KGaA
- Silicon Biosystems
- Bio-Rad Laboratories
- Yikang Gene
- Illumina Inc.
- QIAGEN
Market Classification
· Gene Amplification Technologies Market, By Technology, Estimates and Forecast, 2017-2022 ($Million)
o PCR-based Amplification
o Loop-mediated Isothermal Amplification
o Nucleic Acid Sequence Based Amplification
o Strand Displacement Amplification
o Multiple Displacement Amplification
o Rolling Circle Amplification
o Ramification Amplification
o Others
· Gene Amplification Technologies Market, By Application, Estimates and Forecast, 2017-2022 ($Million)
o Whole Genome Amplification
o Exome Sequencing
o SNP Genotyping Arrays
o Array CGH
o Hybridization
o Others
· Gene Amplification Technologies Market, By End User, Estimates and Forecast, 2017-2022 ($Million)
o Pharmaceutical & Biotechnology Companies
o Academic & Research Institutes
o Others
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Data Mining
1.2.2. Market Modeling and Forecasting
1.2.3. Data Validation
1.2.4. Industry Analysis
2. Market Dashboard
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
4. Gene Amplification Technologies Market, By Technology
4.1. Introduction
4.2. Gene Amplification Technologies Market and Market Growth Rate By Technology (2017-2022)
4.3. PCR-based Amplification
4.3.1. Global PCR-based Amplification Market and Growth Rate (2017-2022)
4.3. Loop-mediated Isothermal Amplification
4.3.1. Global Loop-mediated Isothermal Amplification Market and Growth Rate (2017-2022)
4.3. Nucleic Acid Sequence Based Amplification
4.3.1. Global Nucleic Acid Sequence Based Amplification Market and Growth Rate (2017-2022)
4.3. Strand Displacement Amplification
4.3.1. Global Strand Displacement Amplification Market and Growth Rate (2017-2022)
4.3. Multiple Displacement Amplification
4.3.1. Global Multiple Displacement Amplification Market and Growth Rate (2017-2022)
4.3. Rolling Circle Amplification
4.3.1. Global Rolling Circle Amplification Market and Growth Rate (2017-2022)
4.3. Ramification Amplification
4.3.1. Global Ramification Amplification Market and Growth Rate (2017-2022)
4.3. Others
4.3.1. Global Others Market and Growth Rate (2017-2022)
5. Gene Amplification Technologies Market, By Application
5.1. Introduction
5.2. Gene Amplification Technologies Market and Market Growth Rate By Application (2017-2022)
5.3. Whole Genome Amplification
5.3.1. Global Whole Genome Amplification Market and Growth Rate (2017-2022)
5.3. Exome Sequencing
5.3.1. Global Exome Sequencing Market and Growth Rate (2017-2022)
5.3. SNP Genotyping Arrays
5.3.1. Global SNP Genotyping Arrays Market and Growth Rate (2017-2022)
5.3. Array CGH
5.3.1. Global Array CGH Market and Growth Rate (2017-2022)
5.3. Hybridization
5.3.1. Global Hybridization Market and Growth Rate (2017-2022)
5.3. Others
5.3.1. Global Others Market and Growth Rate (2017-2022)
6. Gene Amplification Technologies Market, By End User
6.1. Introduction
6.2. Gene Amplification Technologies Market and Market Growth Rate By End User (2017-2022)
6.3. Pharmaceutical & Biotechnology Companies
6.3.1. Global Pharmaceutical & Biotechnology Companies Market and Growth Rate (2017-2022)
6.3. Academic & Research Institutes
6.3.1. Global Academic & Research Institutes Market and Growth Rate (2017-2022)
6.3. Others
6.3.1. Global Others Market and Growth Rate (2017-2022)
7. Gene Amplification Technologies Market, By Region
7.1. Introduction
7.2. Gene Amplification Technologies Market and Growth Rate By Regions
6.3. North America
7.3.1. North America Gene Amplification Technologies Market and Growth Rate (2017-2022))
7.3.2. North America Gene Amplification Technologies Market By Technology (2017-2022)
7.3.2. North America Gene Amplification Technologies Market By Application (2017-2022)
7.3.2. North America Gene Amplification Technologies Market By End User (2017-2022)
7.3.4. North America Gene Amplification Technologies Market By Country (2017-2022)
7.3.5. United States
7.3.5.1.United States Gene Amplification Technologies Market and Growth Rate (2017-2022)
7.3.5.2.United States Gene Amplification Technologies Market By Technology (2017-2022)
7.3.5.2.United States Gene Amplification Technologies Market By Application (2017-2022)
7.3.5.2.United States Gene Amplification Technologies Market By End User (2017-2022)
7.3.5. Canada
7.3.5.1.Canada Gene Amplification Technologies Market and Growth Rate (2017-2022)
7.3.5.2.Canada Gene Amplification Technologies Market By Technology (2017-2022)
7.3.5.2.Canada Gene Amplification Technologies Market By Application (2017-2022)
7.3.5.2.Canada Gene Amplification Technologies Market By End User (2017-2022)
6.3. Europe
8.3.1. Europe Gene Amplification Technologies Market and Growth Rate (2017-2022))
8.3.2. Europe Gene Amplification Technologies Market By Technology (2017-2022)
8.3.2. Europe Gene Amplification Technologies Market By Application (2017-2022)
8.3.2. Europe Gene Amplification Technologies Market By End User (2017-2022)
8.3.4. Europe Gene Amplification Technologies Market By Country (2017-2022)
8.3.5. Germany
8.3.5.1.Germany Gene Amplification Technologies Market and Growth Rate (2017-2022)
8.3.5.2.Germany Gene Amplification Technologies Market By Technology (2017-2022)
8.3.5.2.Germany Gene Amplification Technologies Market By Application (2017-2022)
8.3.5.2.Germany Gene Amplification Technologies Market By End User (2017-2022)
8.3.5. France
8.3.5.1.France Gene Amplification Technologies Market and Growth Rate (2017-2022)
8.3.5.2.France Gene Amplification Technologies Market By Technology (2017-2022)
8.3.5.2.France Gene Amplification Technologies Market By Application (2017-2022)
8.3.5.2.France Gene Amplification Technologies Market By End User (2017-2022)
8.3.5. UK
8.3.5.1.UK Gene Amplification Technologies Market and Growth Rate (2017-2022)
8.3.5.2.UK Gene Amplification Technologies Market By Technology (2017-2022)
8.3.5.2.UK Gene Amplification Technologies Market By Application (2017-2022)
8.3.5.2.UK Gene Amplification Technologies Market By End User (2017-2022)
8.3.5. Russia
8.3.5.1.Russia Gene Amplification Technologies Market and Growth Rate (2017-2022)
8.3.5.2.Russia Gene Amplification Technologies Market By Technology (2017-2022)
8.3.5.2.Russia Gene Amplification Technologies Market By Application (2017-2022)
8.3.5.2.Russia Gene Amplification Technologies Market By End User (2017-2022)
8.3.5. Italy
8.3.5.1.Italy Gene Amplification Technologies Market and Growth Rate (2017-2022)
8.3.5.2.Italy Gene Amplification Technologies Market By Technology (2017-2022)
8.3.5.2.Italy Gene Amplification Technologies Market By Application (2017-2022)
8.3.5.2.Italy Gene Amplification Technologies Market By End User (2017-2022)
8.3.5. Rest of Europe
8.3.5.1.Rest of Europe Gene Amplification Technologies Market and Growth Rate (2017-2022)
8.3.5.2.Rest of Europe Gene Amplification Technologies Market By Technology (2017-2022)
8.3.5.2.Rest of Europe Gene Amplification Technologies Market By Application (2017-2022)
8.3.5.2.Rest of Europe Gene Amplification Technologies Market By End User (2017-2022)
6.3. Asia-Pacific
9.3.1. Asia-Pacific Gene Amplification Technologies Market and Growth Rate (2017-2022))
9.3.2. Asia-Pacific Gene Amplification Technologies Market By Technology (2017-2022)
9.3.2. Asia-Pacific Gene Amplification Technologies Market By Application (2017-2022)
9.3.2. Asia-Pacific Gene Amplification Technologies Market By End User (2017-2022)
9.3.4. Asia-Pacific Gene Amplification Technologies Market By Country (2017-2022)
9.3.5. China
9.3.5.1.China Gene Amplification Technologies Market and Growth Rate (2017-2022)
9.3.5.2.China Gene Amplification Technologies Market By Technology (2017-2022)
9.3.5.2.China Gene Amplification Technologies Market By Application (2017-2022)
9.3.5.2.China Gene Amplification Technologies Market By End User (2017-2022)
9.3.5. Japan
9.3.5.1.Japan Gene Amplification Technologies Market and Growth Rate (2017-2022)
9.3.5.2.Japan Gene Amplification Technologies Market By Technology (2017-2022)
9.3.5.2.Japan Gene Amplification Technologies Market By Application (2017-2022)
9.3.5.2.Japan Gene Amplification Technologies Market By End User (2017-2022)
9.3.5. Korea
9.3.5.1.Korea Gene Amplification Technologies Market and Growth Rate (2017-2022)
9.3.5.2.Korea Gene Amplification Technologies Market By Technology (2017-2022)
9.3.5.2.Korea Gene Amplification Technologies Market By Application (2017-2022)
9.3.5.2.Korea Gene Amplification Technologies Market By End User (2017-2022)
9.3.5. India
9.3.5.1.India Gene Amplification Technologies Market and Growth Rate (2017-2022)
9.3.5.2.India Gene Amplification Technologies Market By Technology (2017-2022)
9.3.5.2.India Gene Amplification Technologies Market By Application (2017-2022)
9.3.5.2.India Gene Amplification Technologies Market By End User (2017-2022)
9.3.5. Southeast Asia
9.3.5.1.Southeast Asia Gene Amplification Technologies Market and Growth Rate (2017-2022)
9.3.5.2.Southeast Asia Gene Amplification Technologies Market By Technology (2017-2022)
9.3.5.2.Southeast Asia Gene Amplification Technologies Market By Application (2017-2022)
9.3.5.2.Southeast Asia Gene Amplification Technologies Market By End User (2017-2022)
9.3.5. Rest of Asia-Pacific
9.3.5.1.Rest of Asia-Pacific Gene Amplification Technologies Market and Growth Rate (2017-2022)
9.3.5.2.Rest of Asia-Pacific Gene Amplification Technologies Market By Technology (2017-2022)
9.3.5.2.Rest of Asia-Pacific Gene Amplification Technologies Market By Application (2017-2022)
9.3.5.2.Rest of Asia-Pacific Gene Amplification Technologies Market By End User (2017-2022)
6.3. South America
10.3.1. South America Gene Amplification Technologies Market and Growth Rate (2017-2022))
10.3.2. South America Gene Amplification Technologies Market By Technology (2017-2022)
10.3.2. South America Gene Amplification Technologies Market By Application (2017-2022)
10.3.2. South America Gene Amplification Technologies Market By End User (2017-2022)
10.3.4. South America Gene Amplification Technologies Market By Country (2017-2022)
10.3.5. Brazil
10.3.5.1.Brazil Gene Amplification Technologies Market and Growth Rate (2017-2022)
10.3.5.2.Brazil Gene Amplification Technologies Market By Technology (2017-2022)
10.3.5.2.Brazil Gene Amplification Technologies Market By Application (2017-2022)
10.3.5.2.Brazil Gene Amplification Technologies Market By End User (2017-2022)
10.3.5. Mexico
10.3.5.1.Mexico Gene Amplification Technologies Market and Growth Rate (2017-2022)
10.3.5.2.Mexico Gene Amplification Technologies Market By Technology (2017-2022)
10.3.5.2.Mexico Gene Amplification Technologies Market By Application (2017-2022)
10.3.5.2.Mexico Gene Amplification Technologies Market By End User (2017-2022)
10.3.5. Columbia
10.3.5.1.Columbia Gene Amplification Technologies Market and Growth Rate (2017-2022)
10.3.5.2.Columbia Gene Amplification Technologies Market By Technology (2017-2022)
10.3.5.2.Columbia Gene Amplification Technologies Market By Application (2017-2022)
10.3.5.2.Columbia Gene Amplification Technologies Market By End User (2017-2022)
10.3.5. Rest of South America
10.3.5.1.Rest of South America Gene Amplification Technologies Market and Growth Rate (2017-2022)
10.3.5.2.Rest of South America Gene Amplification Technologies Market By Technology (2017-2022)
10.3.5.2.Rest of South America Gene Amplification Technologies Market By Application (2017-2022)
10.3.5.2.Rest of South America Gene Amplification Technologies Market By End User (2017-2022)
6.3. Middle East and Africa
11.3.1. Middle East and Africa Gene Amplification Technologies Market and Growth Rate (2017-2022))
11.3.2. Middle East and Africa Gene Amplification Technologies Market By Technology (2017-2022)
11.3.2. Middle East and Africa Gene Amplification Technologies Market By Application (2017-2022)
11.3.2. Middle East and Africa Gene Amplification Technologies Market By End User (2017-2022)
11.3.4. Middle East and Africa Gene Amplification Technologies Market By Country (2017-2022)
11.3.5. Saudi Arabia
11.3.5.1.Saudi Arabia Gene Amplification Technologies Market and Growth Rate (2017-2022)
11.3.5.2.Saudi Arabia Gene Amplification Technologies Market By Technology (2017-2022)
11.3.5.2.Saudi Arabia Gene Amplification Technologies Market By Application (2017-2022)
11.3.5.2.Saudi Arabia Gene Amplification Technologies Market By End User (2017-2022)
11.3.5. United Arab Emirates
11.3.5.1.United Arab Emirates Gene Amplification Technologies Market and Growth Rate (2017-2022)
11.3.5.2.United Arab Emirates Gene Amplification Technologies Market By Technology (2017-2022)
11.3.5.2.United Arab Emirates Gene Amplification Technologies Market By Application (2017-2022)
11.3.5.2.United Arab Emirates Gene Amplification Technologies Market By End User (2017-2022)
11.3.5. South Africa
11.3.5.1.South Africa Gene Amplification Technologies Market and Growth Rate (2017-2022)
11.3.5.2.South Africa Gene Amplification Technologies Market By Technology (2017-2022)
11.3.5.2.South Africa Gene Amplification Technologies Market By Application (2017-2022)
11.3.5.2.South Africa Gene Amplification Technologies Market By End User (2017-2022)
11.3.5. Rest of Middle East and Africa
11.3.5.1.Rest of Middle East and Africa Gene Amplification Technologies Market and Growth Rate (2017-2022)
11.3.5.2.Rest of Middle East and Africa Gene Amplification Technologies Market By Technology (2017-2022)
11.3.5.2.Rest of Middle East and Africa Gene Amplification Technologies Market By Application (2017-2022)
11.3.5.2.Rest of Middle East and Africa Gene Amplification Technologies Market By End User (2017-2022)
7. Company Profiles
7.1. Danaher Corporation
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. 4basebio AG
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. LGC Group
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Vazyme Biotech Co. Ltd.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. MyBioSource
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Takara Bio Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Promega Corporation
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Merck KGaA
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Silicon Biosystems
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Bio-Rad Laboratories
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Yikang Gene
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Illumina Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. QIAGEN
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|